1. Dr. Saurabh Gupta M.D. medicine 2. Journal –NEJM Pblished on march 29 2014 3. Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/…
PowerPoint Presentation A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia By : Dr. NITESH PANSARI GUIDE : Dr. HEMANT MAHUR SIR UNIT HEAD & HOD : Dr.…
JOURNAL CLUB JOURNAL CLUB DR.PRAVEEN NAGULA 1 Update on the evidence for PCSK9 inhibition to lower LDL cholesterol NEJM,2014 May 8 ;370:1811. 2 Background For patients who…